Lindsay Weil
NPI 1912561481ActiveIndividual· Colon & Rectal Surgery· Abington, PA
Colon & Rectal Surgery in Abington, Pennsylvania, licensed in PA, with an NPI issued in April 2019. Part D covered 22 prescriptions written in 2024, 91% of them generic. Takeda Pharmaceuticals U.S.A., Inc. reported $19.32 in payments in 2025, mostly food and beverage.
Overview
| NPI | 1912561481 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Sole proprietor | No |
| NPI issued | Apr 30, 2019 |
| Last updated in NPPES | Sep 22, 2026 |
| Certified by provider | Sep 22, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Colon & Rectal Surgery Primary | 208C00000X | MD477577 | PA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Order and Referring Only - General Surgery (PA) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 22 · 22 30-day fills |
|---|---|
| Patients | 16 |
| Total drug cost | $373.56 |
| Generic share | 91% of claims |
Industry payments (Open Payments)
- 2025$19.32 · 1 payment from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $19.32 | 1 |
What the 2025 payments were for
- Food and Beverage$19.32 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other colorectal surgeons in Abington
- 1609865401
- 1780689232
- 1831187996
- 1831193887
- 1639124720
- 1962350744